NCT03062774View on ClinicalTrials.gov

Continuous Multiple Dose PB-119 Injection in Health Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 15, 2014

Primary Completion Date

September 13, 2016

Study Completion Date

October 8, 2016

Conditions
Type2 Diabetes Mellitus
Interventions
BIOLOGICAL

PB-119 injection

Trial Locations (1)

100191

Peking University First Hospital, Beijing

All Listed Sponsors
lead

PegBio Co., Ltd.

OTHER

NCT03062774 - Continuous Multiple Dose PB-119 Injection in Health Volunteers | Biotech Hunter | Biotech Hunter